Open AccessInjectable platelet-rich fibrin (albumin gel and liquid platelet-rich fibrin)
Author(s) -
Gagandeep,
Rupinder Jyot Singh,
BirSukhman Kaur Thind
Publication year - 2021
Publication title -
international journal of health sciences (ijhs) (en línea)
Language(s) - English
Resource type - Journals
eISSN - 2550-6978
pISSN - 2550-696X
DOI - 10.53730/ijhs.v5ns2.5770
Subject(s) - fibrin , platelet rich fibrin , platelet , albumin , in vivo , regeneration (biology) , biomedical engineering , wound healing , implant , dentistry , medicine , surgery , microbiology and biotechnology , immunology , biology
This article provides review on Injectable Platelet-Rich Fibrin (Albumin Gel and Liquid Platelet-Rich Fibrin). The current findings suggest that AlbPRF has regeneration characteristics that are caused by the slow and steady release of growth factors contained in liquid PRF via albumin gel breakdown. Future research is needed to thoroughly define the degrading features of Alb-PRF in vivo and to investigate potential therapeutic uses in other domains of medicine. Platelet concentrates are easy to apply in clinical practice and offer potential benefits including rapid wound healing and bone regeneration, and can therefore be considered to be new therapeutic adjuvants. In dental implant surgery they are used in bone reconstruction prior or concomitant to implant procedures, and also for dental extraction socket preservation.